Yale School of Medicine
T

ACC 21 Highlights: Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction. Results of the LIFE Trial

By Yale School of Medicine FEATURING Tariq Ahmad
June 14, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

37:58
Boston Scientific

Integrated Heart Failure Patient Management — EP and HF Perspective

Feat. M. Fudim, A. Hernandez, C. Frazier-Mills

Related Content

AUTOPLAY
Cleveland Clinic Heart, Vascular and Thoracic Institute

Cardiovascular Update for the Primary Care Provider

Thu, Oct 28, 2021
Houston Methodist DeBakey Heart and Vascular Center

11th Annual Multimodality Cardiovascular Imaging for the Clinician

Sat, Dec 11, 2021
Northwestern Medicine Cardiovascular Care

17th Annual Heart Failure Holiday Symposium

Fri, Dec 10, 2021
05:01
American Heart Association

EMPEROR Reduced Trial: Should You Use Empagliflozin in HFrEF With or Witho…

Feat. M. Packer
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…

Feat. B. Greenberg
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - How to…

12:23
American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Hospital…

Feat. M. Tipton
21:59
Heart Failure 2021: An Update on Therapy

Heart Failure With Recovered EF: Definition, Natural History and Managemen…

Feat. U. Elkayam
14:44
26th Annual San Diego Heart Failure Symposium

Broadening Indications for the Use of Angiotensin Receptor Neprilysin Inhi…

Feat. C. Yancy
63:10
Cardiac Contractility Modulation

Failure Is not an Option! Implementing CCM into your Practice

Feat. F. Syed, M. Goldschmidt, I. Rao
64:40
Cardiac Contractility Modulation

CCM® Therapy - Mechanism of Action, Patient Selection and Identification

Feat. A. Kaplan, H. Saltzman
16:54
Cardiac Contractility Modulation

Cardiac Contractility Modulation: How it Works

Feat. J. Ehrlich, H. Levin
24:58
Boston Scientific

How to Manage HF using a Remote Heart Failure Diagnostic and Monitoring So…

Feat. J. Boehmer
05:10
Boston Scientific

HeartLogic™: The First FDA-Approved Predictive Analytic Alert in an Implan…

Feat. A. Hernandez, J. Boehmer, J. Singh, C. Fier, N. Albert
88:01
Cardiac Contractility Modulation

The Comparison and Advantages of the Use of Device Therapy in Heart Failur…

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao
61:12
Cardiac Contractility Modulation

Assessing Heart Failure Patients - Where Does CCM® Therapy Fit

Feat. S. Brune, N. Bonnet, M. Arnold
18:35
Heart Failure 2021: An Update on Therapy

SGLT2 Inhibitors for HF: What Is the Effect of Empagliflozin on Cardiovasc…

Feat. M. Packer
21:28
Keck School of Medicine of USC

Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to…

Feat. H. Van Herle
27:33
Boston Scientific

Multi-Sensor Heart Failure Monitoring: What Are the Benefits of HeartLogic…

Feat. J. Boehmer
17:09
Heart Failure 2021: An Update on Therapy

Peripartum Cardiomyopathy: Treatment Considerations in the Context of Yout…

Feat. M. Davis
17:23
Northwestern Medicine: 8th Annual Cardiovascular Update

AF and Heart Failure: What’s the Risk? Is Ablation the Answer?

Feat. J. Piccini
33:38
Cardiac Contractility Modulation

AAHFN Advanced 2020 - CCM® in HF - Mechanism and Clinical Evidence

Feat. R. Kahwash, N. Albert
17:22
Getinge

IABP case study in Advance Heart Failure

Feat. J. Estep